Search alternatives:
point decrease » point increase (Expand Search)
d decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
d decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
40381
Table1_The response of human macrophages to 3D printed titanium antibacterial implants does not affect the osteogenic differentiation of hMSCs.DOCX
Published 2023“…These specimens also caused a decrease of the macrophage tissue repair related factor C-C Motif Chemokine Ligand 18 (CCL18). …”
-
40382
-
40383
Reduction of myc-Nkx2.5 protein in cells treated with <i>O</i>-GlcNAcase inhibotirs.
Published 2013“…<p>(A) Immunoblotting of myc-Nkx2.5 and <i>O</i>-GlycNAcylated proteins in myc-Nkx2.5-transfected HEK293 cells in the presence or absence of 3 mM streptozotocine (STZ). …”
-
40384
Image_1_Venlafaxine Attenuated the Cognitive and Memory Deficit in Mice Exposed to Isoflurane Alone.pdf
Published 2021“…We found that ISO significantly induced an increased surface expression of the GABA<sub>A</sub> receptor subunit, α5, in the hippocampus of the mice. …”
-
40385
-
40386
-
40387
Supplementary Material for: A Placebo-Controlled, Randomized Trial of Enarodustat in Patients with Chronic Kidney Disease Followed by Long-Term Trial
Published 2019“…<b><i>Methods:</i></b> Erythropoiesis-stimulating agent (ESA) naïve patients (correction group) and patients on a stable dose of ESA (conversion group) were randomized to receive 2, 4, or 6 mg of enarodustat or placebo once daily for 6 weeks in a double-blind manner (Period 1) followed by 24 weeks of open enarodustat treatment to maintain their hemoglobin (Hb) levels within a target range of 10.0–12.0 g/dL in reference to a dose adjustment algorithm (Period 2). …”
-
40388
-
40389
-
40390
-
40391
-
40392
Understanding the Effect of Platinum Particle Size on Ethane Dehydrogenation and Hydrogenolysis: Particle-Based Microkinetic Modeling at Finite Conversion
Published 2025“…The effect of platinum particle size on the kinetics and mechanism of ethane dehydrogenation (EDH) and hydrogenolysis (EH) is elucidated using first-principles and multiscale modeling. A particle-based microkinetic modeling (PB-MKM) approach is used to couple the MKMs for individual facets, i.e., Pt(111), Pt(100), and Pt(211), into a variable-size Pt nanoparticle catalyst model. …”
-
40393
Understanding the Effect of Platinum Particle Size on Ethane Dehydrogenation and Hydrogenolysis: Particle-Based Microkinetic Modeling at Finite Conversion
Published 2025“…The effect of platinum particle size on the kinetics and mechanism of ethane dehydrogenation (EDH) and hydrogenolysis (EH) is elucidated using first-principles and multiscale modeling. A particle-based microkinetic modeling (PB-MKM) approach is used to couple the MKMs for individual facets, i.e., Pt(111), Pt(100), and Pt(211), into a variable-size Pt nanoparticle catalyst model. …”
-
40394
Understanding the Effect of Platinum Particle Size on Ethane Dehydrogenation and Hydrogenolysis: Particle-Based Microkinetic Modeling at Finite Conversion
Published 2025“…The effect of platinum particle size on the kinetics and mechanism of ethane dehydrogenation (EDH) and hydrogenolysis (EH) is elucidated using first-principles and multiscale modeling. A particle-based microkinetic modeling (PB-MKM) approach is used to couple the MKMs for individual facets, i.e., Pt(111), Pt(100), and Pt(211), into a variable-size Pt nanoparticle catalyst model. …”
-
40395
Understanding the Effect of Platinum Particle Size on Ethane Dehydrogenation and Hydrogenolysis: Particle-Based Microkinetic Modeling at Finite Conversion
Published 2025“…The effect of platinum particle size on the kinetics and mechanism of ethane dehydrogenation (EDH) and hydrogenolysis (EH) is elucidated using first-principles and multiscale modeling. A particle-based microkinetic modeling (PB-MKM) approach is used to couple the MKMs for individual facets, i.e., Pt(111), Pt(100), and Pt(211), into a variable-size Pt nanoparticle catalyst model. …”
-
40396
-
40397
-
40398
-
40399
<i>V</i><sub>m</sub>-dependent modulation of the slow recurrent inhibition is mediated by LTS interneurons.
Published 2011“…Note the facilitated EPSPs. (D) The failure rate of the 2<sup>nd</sup> to 5<sup>th</sup> EPSPs decreased after presynaptic depolarization. …”
-
40400